Justin Gainor, MD, a thoracic oncologist at the Mass General Cancer Center, conducts intensive research on developing novel targeted therapies for patients with genetically-defined forms of lung cancer and designs clinical trials to evaluate these complex, life-saving treatments.
Concurrently, he is delving into the role of the immune system as a means to combat cancer. In recent years, immunotherapies targeting the PD-1 protein have reshaped the management of a number of malignancies. Dr. Gainor is now spearheading Mass General’s clinical trials assessing similar strategies in lung and esophageal cancer. Lastly, he is exploring the intersection of targeted therapies and immunotherapy, both on a clinical and translational level.
Thoracic cancer patients struggling to beat their disease benefit both from Dr. Gainor’s advanced research and his dedicated clinical care, as well as his random acts of kindness, which his colleague Kimberly Lewis, NP, has witnessed firsthand.
Says Kimberly: “Dr. Gainor is making a difference in the fight against cancer not only through his skill and talent as a researcher, but also by his generosity and patience as an attending physician.”